The Trump administration’s approach to autism is tangled up with ableism, eugenics, and pronatalism
By Shoumita Dasgupta,
STAT
| 10. 03. 2025
President Trump and health secretary Robert F. Kennedy Jr. have characterized the rise in autism diagnoses in recent years as an epidemic requiring emergency intervention.
This approach is factually wrong: The broadening definition of autism and the improvement in diagnosis in the same time period is largely responsible for the rise. But it’s worse than a simple factual error. Using this framing dehumanizes autistic people in ways that echo the eugenic policies of the early 20th century and is just the latest iteration of politicizing and codifying harmful eugenic frameworks.
Eugenic policies originally sought to improve society by enriching good genes through selective breeding strategies co-opted from agricultural practices and applied to human populations. Inherent in these policies was a hierarchical worth of human traits, a ranking and designation of some lives as not worth living. The Trump administration is reviving eugenic thinking, most recently by targeting autistic people as undesirable lives to be purged from society whether by restricting acetaminophen use during pregnancy (even though the data does not support such a connection), withholding vaccines from children (even though ...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...